Basiliximab is superior to low dose rabbit anti-thymocyte globulin in pediatric kidney transplant recipients: The younger, the better

被引:0
|
作者
Zhu Lan [1 ]
Zhang Lei [2 ]
Shang Wenjun [3 ]
Liu Wenhua [4 ]
Sa Rula [1 ]
Guo Zhiliang [1 ]
Liu Longshan [5 ]
Tan Jinghong [5 ]
Zhang Hengxi [5 ]
Feng Yonghua [3 ]
Zhao Wenyu [2 ]
Cong Wenqi [6 ]
Wu Jianyong [6 ]
Wang Changxi [5 ]
Chen Gang [1 ]
机构
[1] Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Key Laboratory of Organ Transplantation, Ministry of Education, NHC Key Laboratory of Organ Transplantation, Key Laboratory of Organ
[2] Department of Organ Transplantation, First Affiliated Hospital, Naval Medical University, Shanghai, China
[3] Department of Renal Transplantation, First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China
[4] Clinical Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
[5] Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
[6] Center of Nephrology, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang,
关键词
D O I
暂无
中图分类号
R726.9 [小儿泌尿科学];
学科分类号
摘要
<正>
引用
收藏
相关论文
共 50 条
  • [21] Use of rabbit anti-thymocyte globulin for induction immunosuppression in high-risk kidney transplant recipients
    Belitsky, P
    MacDonald, AS
    Lawen, J
    McAlister, V
    BitterSuermann, H
    Kiberd, B
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (7A) : S16 - S17
  • [22] Induction in the Elderly: A Comparison of Basiliximab versus Rabbit Anti-Thymocyte Globulin After Kidney Transplantation
    Lee, J.
    Liu, E.
    Aull, M.
    Kapur, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 574 - 574
  • [23] Cryptococcosis in liver and kidney transplant recipients receiving anti-thymocyte globulin or alemtuzumab
    Silveira, F. P.
    Husain, S.
    Kwak, E. J.
    Linden, P. K.
    Marcos, A.
    Shapiro, R.
    Fontes, P.
    Marsh, J. W.
    de Vera, M.
    Tom, K.
    Thai, N.
    Tan, H. P.
    Basu, A.
    Soltys, K.
    Paterson, D. L.
    TRANSPLANT INFECTIOUS DISEASE, 2007, 9 (01) : 22 - 27
  • [24] EXPERIENCE WITH ANTI-THYMOCYTE GLOBULIN (ATG) IN PEDIATRIC RENAL-TRANSPLANT RECIPIENTS
    COTE, ML
    GRUSKIN, AB
    BALUARTE, HJ
    SOMERS, LA
    LISCHNER, HW
    PEDIATRIC RESEARCH, 1980, 14 (08) : 992 - 992
  • [25] Anti-thymocyte Globulin versus Basiliximab Induction in Renal Transplant Recipients: Long-term Outcome
    Kesiraju, Sailaja
    Paritala, Purna
    Rao, Uma Maheswara Ch
    Athmakuri, Srinivasa Murthy
    Reddy, V. S.
    Sahariah, S.
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2014, 25 (01) : 9 - 15
  • [26] Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients
    Pennington, Catherine A.
    Tischer, Sarah M.
    Lee, Eliza
    Lee, Sun
    Sindelar, James, Jr.
    Park, Jeong M.
    PHARMACOTHERAPY, 2015, 35 (08): : 748 - 754
  • [27] Reduced dose rabbit anti-thymocyte globulin induction is effective in preventing acute rejection in high-risk kidney transplant recipients
    Klem, Patrick
    Weiss, Andrew
    Gralla, Jane
    Owen, Phillip
    Wiseman, Alexander
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 438 - 438
  • [28] Infectious Complications in Pediatric Renal Transplant Recipients Who Received Alemtuzumab or Rabbit Anti-Thymocyte Globulin Induction
    Doares, W.
    Chen, A.
    Lin, J. -J.
    Hart, L.
    Spainhour, L.
    Kaczmorski, S.
    Rogers, J.
    Stratta, R.
    Farney, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 440 - 441
  • [29] Evaluating anti-thymocyte globulin induction doses for better allograft and patient survival in Asian kidney transplant recipients
    Ye Eun Shim
    Youngmin Ko
    Jung Pyo Lee
    Jin Seok Jeon
    Heungman Jun
    Jaeseok Yang
    Myoung Soo Kim
    Seong Jun Lim
    Hye Eun Kwon
    Joo Hee Jung
    Hyunwook Kwon
    Young Hoon Kim
    Jungbok Lee
    Sung Shin
    Scientific Reports, 13
  • [30] A comparative study between low dose anti-thymocyte globulin versus basiliximab as induction therapy for standard immunologic risk kidney transplant patients
    David, Paolo Miguel
    Pamugas, Glenda Eleanor P.
    TRANSPLANTATION, 2016, 100 (07) : S166 - S166